Pbc Invest Information

Pharmaceuticals
FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment Jun 12, 2024
Pharmaceuticals
GENFIT Reaches Historic FDA Approval with Ipsen's Iqirvo® for Primary Biliary Cholangitis Jun 11, 2024
Biopharmaceutical
GENFIT Foresees Growth with Elafibranor Approvals for PBC Across US and Europe Dec 9, 2023